Moloney Securities Asset Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.94M | Sell |
13,967
-1,044
| -7% | -$303K | 0.47% | 48 |
|
|
2025
Q2 | $4.19M | Sell |
15,011
-2,270
| -13% | -$643K | 0.52% | 36 |
|
|
2025
Q1 | $5.38M | Buy |
17,281
+3,354
| +24% | +$990K | 0.73% | 26 |
|
|
2024
Q4 | $3.63M | Sell |
13,927
-259
| -2% | -$76.8K | 0.49% | 52 |
|
|
2024
Q3 | $4.57M | Sell |
14,186
-926
| -6% | -$303K | 0.61% | 36 |
|
|
2024
Q2 | $4.72M | Sell |
15,112
-2,320
| -13% | -$682K | 0.68% | 33 |
|
|
2024
Q1 | $4.96M | Buy |
17,432
+1,374
| +9% | +$402K | 0.75% | 29 |
|
|
2023
Q4 | $4.63M | Sell |
16,058
-165
| -1% | -$45K | 0.73% | 27 |
|
|
2023
Q3 | $4.36M | Sell |
16,223
-17
| -0.1% | -$4.24K | 0.79% | 23 |
|
|
2023
Q2 | $3.61M | Buy |
16,240
+2,344
| +17% | +$544K | 0.64% | 38 |
|
|
2023
Q1 | $3.36M | Sell |
13,896
-1,701
| -11% | -$418K | 0.63% | 37 |
|
|
2022
Q4 | $4.1M | Sell |
15,597
-375
| -2% | -$101K | 0.9% | 22 |
|
|
2022
Q3 | $3.6M | Sell |
15,972
-79
| -0.5% | -$19.1K | 0.87% | 23 |
|
|
2022
Q2 | $3.9M | Sell |
16,051
-492
| -3% | -$121K | 0.91% | 22 |
|
|
2022
Q1 | $4M | Buy |
16,543
+1,542
| +10% | +$354K | 0.78% | 26 |
|
|
2021
Q4 | $3.38M | Sell |
15,001
-287
| -2% | -$60.6K | 0.57% | 39 |
|
|
2021
Q3 | $3.25M | Buy |
15,288
+618
| +4% | +$142K | 0.59% | 46 |
|
|
2021
Q2 | $3.58M | Buy |
14,670
+634
| +5% | +$156K | 0.65% | 40 |
|
|
2021
Q1 | $3.49M | Sell |
14,036
-1,727
| -11% | -$412K | 0.69% | 37 |
|
|
2020
Q4 | $3.62M | Sell |
15,763
-754
| -5% | -$174K | 0.8% | 25 |
|
|
2020
Q3 | $4.2M | Buy |
16,517
+1,198
| +8% | +$297K | 1.11% | 18 |
|
|
2020
Q2 | $3.61M | Buy |
15,319
+129
| +0.8% | +$29.4K | 1.05% | 18 |
|
|
2020
Q1 | $3.08M | Buy |
15,190
+3,452
| +29% | +$754K | 1.1% | 20 |
|
|
2019
Q4 | $2.83M | Buy |
11,738
+808
| +7% | +$178K | 0.87% | 24 |
|
|
2019
Q3 | $2.12M | Buy |
10,930
+12
| +0.1% | +$2.3K | 0.71% | 36 |
|
|
2019
Q2 | $2.01M | Sell |
10,918
-27
| -0.2% | -$4.83K | 0.67% | 36 |
|
|
2019
Q1 | $2.08M | Buy |
10,945
+938
| +9% | +$179K | 0.72% | 34 |
|
|
2018
Q4 | $1.95M | Sell |
10,007
-277
| -3% | -$54K | 0.8% | 29 |
|
|
2018
Q3 | $2.13M | Sell |
10,284
-57
| -0.6% | -$11.2K | 0.74% | 33 |
|
|
2018
Q2 | $1.91M | Buy |
10,341
+805
| +8% | +$142K | 0.72% | 35 |
|
|
2018
Q1 | $1.63M | Sell |
9,536
-372
| -4% | -$68.3K | 0.66% | 38 |
|
|
2017
Q4 | $1.72M | Sell |
9,908
-573
| -5% | -$101K | 0.72% | 33 |
|
|
2017
Q3 | $1.95M | Buy |
10,481
+1,084
| +12% | +$192K | 0.87% | 27 |
|
|
2017
Q2 | $1.62M | Buy |
9,397
+1,091
| +13% | +$177K | 0.81% | 32 |
|
|
2017
Q1 | $1.36M | Buy |
8,306
+1,578
| +23% | +$262K | 0.71% | 39 |
|
|
2016
Q4 | $984K | Buy |
+6,728
| New | +$1.01M | 0.59% | 42 |
|
Other funds holding AMGN
Moloney Securities Asset Management's AMGN Position: Q3 2025 in Review
Moloney Securities Asset Management reduced its Amgen (AMGN) stake by 7% in Q3 2025, selling an estimated $303K and leaving 13,967 shares worth $3.94M. The position accounts for 0.47% of the portfolio, ranked #48.
Moloney Securities Asset Management first reported a position in AMGN in Q4 2016 and has held it in 36 quarters since. The position peaked at $5.38M in Q1 2025. 2,819 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.
- Moloney Securities Asset Management held 13,967 shares of Amgen worth $3.94M as of Q3 2025.
- Moloney Securities Asset Management sold 1,044 Amgen shares in Q3 2025, an estimated $303K.
- Amgen made up 0.47% of Moloney Securities Asset Management's portfolio in Q3 2025, its #48 holding.
- Moloney Securities Asset Management first reported a position in Amgen in Q4 2016 and has held it in 36 quarters since.
- Moloney Securities Asset Management's Amgen position peaked at $5.38M in Q1 2025.
- 2,819 funds tracked by Wall St. Rank held Amgen as of Q3 2025.
Based on Moloney Securities Asset Management's 13F filing for Q3 2025, filed 5 Nov 2025.